MDxHealth SA (NASDAQ: MDXH)
$2.89
+0.1260 ( +4.56% ) 23.8K
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
Market Data
Open
$2.89
Previous close
$2.76
Volume
23.8K
Market cap
$79.14M
Day range
$2.77 - $2.91
52 week range
$2.21 - $39.34
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 5 | Jul 08, 2024 |
6-k | Quarterly Reports | 2 | Jun 20, 2024 |
6-k | Quarterly Reports | 6 | Jun 05, 2024 |
6-k | Quarterly Reports | 15 | May 16, 2024 |
6-k | Quarterly Reports | 1 | May 06, 2024 |
6-k | Quarterly Reports | 10 | May 01, 2024 |
6-k | Quarterly Reports | 3 | May 01, 2024 |
20-f | Annual reports | 169 | Apr 30, 2024 |
6-k | Quarterly Reports | 3 | Mar 12, 2024 |
6-k | Quarterly Reports | 4 | Mar 06, 2024 |